1 story in the last 7 days
The latest montana news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks montana across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Montana's SB535, signed into law in May 2025, authorizes investigational drugs that have cleared Phase I trials to be prescribed and sold, bypassing the traditional FDA approval pathway. The law makes Montana the first state to license experimental treatment centers, positioning it as a highly attractive location for biopharma and life sciences.
Summaries by ByteBrief